Cloning and expression of soluble recombinant HIV-1 CRF35 protease-HP thioredoxin fusion protein
AJMB-Avicenna Journal of Medical Biotechnology. 2016; 8 (4): 175-181
en Inglés
| IMEMR
| ID: emr-185092
ABSTRACT
Background:
As a drug target and an antigenic agent, HIV-1 protease [HIV-1 PR] is at the center of attention for designing anti-AIDS inhibitors and diagnostic tests. In previous studies, the production of the recombinant protease has been faced with several difficulties; therefore, the aims of this study were the easy production, purification of the soluble form of protease in E. coli and investigation of its immunoreactivity
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Inglés
Revista:
Avicenna J. Med. Biotechnol.
Año:
2016
Similares
MEDLINE
...
LILACS
LIS